C12N 2795/10361
Methods of inactivation or attenuation
C12N2795/10361 (Methods of inactivation or attenuation) appears on 13 US grants and 12 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 12
- Assignees
- 13
- Inventors
- 26
- Latest grant
- 20 Aug 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 2 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Viral synthetic nucleic acid sequences and use thereof20 Aug 2024US 12,065,651 B2Synvaccine Ltd.
- Methods for treating spinal muscular atrophy24 Mar 2015US 8,986,935 B2PTC Therapeutics, Inc.
- Screening assays for compounds that modulate programmed ribosomal frameshifting13 Jan 2015US 8,932,818 B2PTC Therapeutics, Inc.
- Method of inactivation of viral and bacterial blood contaminants13 Feb 2001US 6,187,572 B1Baxter International Inc.
- Bacteriophage genotypically modified to delay inactivations by the host defense system22 Sep 1998US 5,811,093 AExponential Biotherapies, Inc.
- Continuous Multiplexed Phage Genome Engineering Using a Retron Editing Template17 Jul 2025US 2025/0230429 A1The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Glads
- Viral synthetic nucleic acid sequences and use thereof28 Nov 2019US 2019/0359990 A1Synvaccine Ltd.
- Methods for treating viral infections3 Dec 2015US 2015/0344877 A1PTC Therapeutics, Inc.
- Methods for treating spinal muscular atrophy8 Oct 2015US 2015/0283115 A1PTC Therapeutics, Inc.
- Methods for treating viral infections1 Sep 2011US 2011/0213005 A1PTC Therapeutics, Inc.
Most cited
By later US patents
- Method of inactivation of viral and bacterial blood contaminants114US 5,418,130 ACryopharm Corporation · 1995
- Method of inactivation of viral and bacterial blood contaminants64US 6,187,572 B1Baxter International Inc. · 2001
- Method of inactivation of viral blood contaminants using acridine deriatives55US 5,342,752 ACryopharm Corporation · 1994
- Method of inactivation of viral and bacterial blood contaminants54US 5,587,490 ACredit Managers Association of California · 1996
- Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system48US 5,688,501 AExponential Biotherapies, Inc. · 1997